Completed PHASE2 INTERVENTIONAL 1-arm NCT03017846

Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2

Sponsor: Steven R Cohen

Interventions Cantharidin

Updated 8 times since 2017 Last updated: Jan 10, 2019 Started: Sep 30, 2016 Primary completion: Sep 6, 2017 Completion: Sep 6, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03017846, this PHASE2 trial focuses on Molluscum Contagiosum and remains completed. Sponsored by Steven R Cohen, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Feb 2019 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed PHASE2
Oct 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Enrolling By Invitation → Completed
Feb 2017 — Oct 2017 [monthly]

Enrolling By Invitation PHASE2

First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Steven R Cohen

Data source: Montefiore Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• The Bronx, United States